Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2022-01-01
2023-03-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inverted ILM-flap Techniques Variants for Macular Hole Surgery: Outcomes Comparison
NCT04135638
Single Superior ILM/ERM Flap for the FTMH.
NCT05494242
Visual Acuity and Optical Coherence Tomography One Year After ILM-flap Transposition
NCT03465865
Inverted Internal Limiting Membrane Flap Technique for Macular Hole Retinal Detachment in Highly Myopic Eyes
NCT02896972
High Myopia Macular Hole and Retinal Detachment Treated With Double ILM Flaps
NCT03174639
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Therefore, the investigators tried to make two flaps utilizing ILM, and sometimes certain patients have a very thin membrane over the retina; it is called epiretinal membrane (ERM). The investigators use the double flapping technique by utilizing ERM; therefore, the ILM remains and can be used if the hole resists closing with the first surgical interventions.
Here, the investigators did not use any new materials with unknown side effects on the human retina. Although the flap technique is well known; however, investigators are making a double flap to decrease the chance of persisting macular holes.
The visual recovery will be appeared in the post-operative period, whether it is the same, better, or worse.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Double flap technique to secure macular hole closure.
Single ILM flap technique is already performing worldwide; however, sometimes it is associated with flap displacement. To overcome this issue, the double flap technique was tried.
Surgical intervention
Pars Plana Vitrectomy for Macular Hole Closure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgical intervention
Pars Plana Vitrectomy for Macular Hole Closure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Vitreomacular traction
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Omer Othman Abdullah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Omer Othman Abdullah
Associate consultant ophthalmologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Omer Abdullah, M.Sc.
Role: PRINCIPAL_INVESTIGATOR
Ibinsina Modern Eye and Retina Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ibinsina Modern eye and retina center
Erbil, , Iraq
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IMER 11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.